首页 正文

Navigating the benefits and harms of GLP-1 and GLP-1/GIP agonists in obesity

{{output}}
Obesity is becoming increasingly common worldwide. Glucagon-like peptide-1 receptor agonist (GLP-1 RA) type drugs have the potential to help patients achieve considerable weight loss. Several benefits have been described in the short term, especially relating ... ...